This course, designed for personnel within organisations that
deal with the pharmaceutical and biotechnology industries, has been
delivered in various formats since 2004. Delegates have come
biotechnology hubs, recruitment agencies, university technology
transfer departments and providers of scientific, financial, and
legal services.
It is normally available through OBN’s BioLearn as a half day course delivered in person, but was run as a shorter online version during the COVID-19 restrictions.
A bespoke version of the course is also available for
technical and medical translators and for organisations who
want the content tailored to their specific interests.
Course outline
The drug discovery and development is highly complex and involves
many players. Some course attendees, particularly those without a
scientific background, may therefore find some of the jargon quite
daunting.
Agenda
Introductory overview
The Commercial Landscape
Global pharmaceutical sales
Market breakdown
Pharma companies
Drug Discovery & Development
Therapeutic areas
Different types of drug molecule
Drug discovery pipeline
Regulatory agencies
Preclinical development
Clinical trials
Registration and marketing
Industry challenges
Rare diseases and orphan drugs
IP and Generics
Increasing R&D productivity
Modern biopharma R&D
Drug targets: genomics etc
Small molecule discovery
Agonists/antagonists
Large molecule discovery
Cell and gene therapy
Immunotherapy
Targeted protein degradation
Machine learning/AI
Further reading
“I would like to give some feedback on Ed's sessions. I totally loved them.
He is really good and the content is top. I really hope we have more
sessions like this in the future. Really amazing talk!” Delegate AI company
“Our team had an excellent day and all took something positive from the
course, we certainly are far better prepared to handle future projects
within the industry. Ed was an excellent teacher, and went at a pace that
allowed us to take everything in, whilst still covering the entire drug
production process - we highly recommend the course.” Laurence
Emmett, Director, Cranleigh Scientific
"The training was exactly what we wanted for our staff member who now has a
rounded appreciation of the pharma / biotech industry, understands the R&D
process and has a good understanding of the science behind the scenes. In
her role as a science recruiter she is now able to identify strong
candidates by intelligently spotting keywords and techniques on CVs whilst
also interviewing people at a more in depth, technical level. Fantastic
results - I can highly recommend PharmaGuide’s services." Ajay Patel,
Recruitment Operations Manager, CK Science
“Shortly after attending the course I had a meeting with one of our biotech
clients who later complimented me on my grasp of technical language. The day
spent in Cambridge learning about the drug discovery business was definitely
worthwhile!” Alex Malocca, Great Guns Marketing
"I do recommend this workshop. I attended last year and it was superb.
Although he starts very slowly, explaining basic chemistry concepts (which I
knew as I used to be a very good student and now I am just lazy), it gathers
pace once it gets to the drugs themselves. I can say I learned a lot and it
has been a great help as I do lots of work on clinical trials and clinical
studies. It was worth every penny." Ana Luiza Iaria, MSc,
MCIL, MITI.
“The course was well-paced and timed with opportunities for participants to
ask questions and clarification of key points, and these were all answered
during the day. There was a positive and friendly atmosphere throughout, and
my impression was that all the translators present enhanced their learning
and understanding of chemistry and were very satisfied with the event.”
Miriam Bianco, York ITI group (for a fuller review, see
link)
The drug discovery course for translators has been reviewed in the ITI
Bulletin download article
and in
a 2014 blog by Katarzyna Slobodzian-Taylor of Mastermind Translations.